Home MarketAlkem Laboratories Ltd.

Alkem Laboratories Ltd. Stock Info: As on 2018-05-24 15:45:14

Nse

1957.55

-7.80(-0.40%)
Change%
52 Week Range
1,578.30
11.00
2,469.00
10.00
Open1,956.75
Day's Range1,572.28 - 2,358.42
Value Traded (in ₹ Cr.) 2.58

Bse

1938.45

-19.80(-1.01%)
Change %
52 Week Range
1,578.00
11.00
2,468.00
10.00
Open1,955.20
Day's Range1,566.60 - 2,349.90
Value Traded (in ₹ Cr.) 2.13

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 78,743,333.00 65.86%
Mutual Funds/UTI 3,465,569.00 2.90%
FII 4,308,479.00 3.60%
Employee 0.00 0.00%
Public 30,390,307.00 25.42%
Government 0.00 0.00%
Others 2,158,937.00 1.81%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 5.65
Basic EPS (Rs.) 73.86
Cash EPS 80.27
BVPerShare Excl 367.43
Operating Revenue 390.50
PBDITPerShare 83.19
Dividend 6.00
NPPerShare 73.87
Current Ratio 1.59
Quick Ratio 0.98
PriceToBV 6.01
Earnings 0.03
PBDIT Margin 21.30
PBT Margin 19.15
NP Margin 18.91
Return On Assets 14.97
Retention Ratios 91.87
Parameter Mar-17 (₹ Cr.) Yoy%change
Total Income 4,785.05
Total Expenses 3,890.62
EBITDA 994.59
PBT 894.43
PAT 883.16
Net Income 883.16
More
Parameter Sep-17 (₹ Cr.) 6M % change
Total Income 2,739.24
Total Expenses 2,150.45
EBITDA 539.62
PBT 569.96
PAT 442.88
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-17 (₹ Cr.) Yoy%change
Total share capital 23.91
Net worth 4,392.65
Investments 1,517.64
Total Liability 5,898.35
Total debt 368.23
Net block 1,344.07
Total Assets 5,898.35
Parameter Sep-17 (₹ Cr.) 6M % change
Total share capital 23.91
Net worth 3,472.04
Investments 1,063.05
Total Liability 5,118.18
Total debt 872.21
Net block 987.26
Total Assets 5,118.18
Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

533.05 531.95 0.21
524.95580

Abbott India Ltd.

6671.7 6587.45 1.28
65106890

Ajanta Pharma Ltd.

977.6 987 -0.95
962.351074.5

Albert David Ltd.

362.35 362.75 -0.11
356.2383.15

Alembic Ltd.

48.85 50.8 -3.84
50.254

Alembic Pharmaceuticals Ltd.

420.7 422.3 -0.38
418.5491.2

Alpa Laboratories Ltd.

32.1 32.55 -1.38
31.5534.4
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

47.5 49.05 -3.16
46.351.55

Aarti Drugs Ltd.

530 529.15 0.16
526585

Aayush Food & Herbs Ltd.

47.7 48.1 -0.83
4355

Abbott India Ltd.

6699.95 6593.7 1.61
6465.056872.5

ABL Bio-Technologies Ltd.

0.81 0.78 3.85
0.750.81

Addlife Pharma Ltd.

0.46 0 0
0.460.5

Adinath Bio-Labs Ltd.

0.3 0.31 -3.23
0.30.3
More
Parameter Mar-17(in ₹ Cr.)
Cash from operating activities 496.48
Cash from investing activities -361.90
Cash from financing activities -122.06
Net change in cash 12.52

Stock Held By Mutual Fund Schemes

Corporate Details

About Management

The Company was incorporated as a private limited company `Alkem Laboratories Private Limited' on August 8,1973 at Patna under the Companies Act, 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act, 1956 on October 26, 1988. Pursuant to the Company passing a resolution under section 21 of Companies Act, 1956 and upon issuance of a fresh certificate of incorporation consequent on change of name dated August 21, 2001, the name of the Company was changed to `Alkem Laboratories Limited' with effect from October 26, 1988. the registered office was originally located at `Exhibition Road, Patna - 800 001, Bihar, India'. the Company filed Company Petition No. 356(17)/ ERB/ 2007 before the Company Law Board, Eastern Region Bench at Kolkata for shifting the registered office of the Company from the State of Bihar to the State of Maharashtra, as approved by a special resolution at its extra-ordinary general meeting held on January 29, 2007. The Company Law Board, Eastern Region Bench at Kolkata passed an order dated July 30, 2007 whereby it confirmed the alteration of the situation clause in the Memorandum of Association, from the State of Bihar to the State of Maharashtra. Pursuant to the order, the registered office of the Company was shifted to `Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai - 400 013, Maharashtra, India' with effect from August 2, 2007. Major Events : 1973 -Incorporation of the Company. 1978 -the Company established its first plant at Taloja, Maharashtra. 1988 -the Company became a deemed public limited company. 1992 -the Company established its manufacturing facility in Mandwa, Maharashtra. This facility was converted into an API facility in 2005. 1998 -the Company established its Kachigam manufacturing facility in Gujarat. 2001 -Startronic Pharmachem Private Limited and Indo Propkem amalgamated with the Company. 2002 -the Company established its Amaliya manufacturing facility in Gujarat. 2003 -the Company set up its research and development facility at Taloja, Maharashtra. 2005 -the Company established its manufacturing facility in Baddi, Himachal Pradesh. 2006 -the anti-infective drug Taxim became the first drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India (Source: IMS Research) 2007 -the Company established its manufacturing facility in Kumrek, Sikkim. -the Company filed its first ANDA in the United States for the drug, Amlodipine. -the Company shifted its Registered Office from Patna, Bihar to Mumbai, Maharashtra. 2009 -the Company acquired Pharmacor, a generic pharma company in Australia. 2010 -the Company acquired The PharmaNetwork, LLC, the holding company of Ascend Laboratories LLC. 2011 -the Company acquired Enzene Bio sciences Limited. 2012 -the Company acquired an API manufacturing facility in the United States. 2014 -the Company acquired the Clindac. 2015 -the Company acquired a formulation manufacturing facility in the United States. Awards and achievements: 2002 -the Company was awarded the Pharma Business and Technology Excellence Award in 2002 as 'India's Most Esteemed Pharmaceutical Company' 2004 -the product Taxim was awarded the Pharma Business and Technology Excellence Award for successful brand in 2004 2005 -the Company was awarded the Overall Performance Award for Group B at the 5th Express Pharma Awards in 2005 2009 -the Company received a certificate of appreciation for outstanding export performance in the category of formulations by the Pharmaceuticals Export Promotion Council of India, supported by Ministry of Commerce and Industry, GOI -the Company received the certificate of appreciation in the category of `Formulation Experts' by the Pharmaceuticals Export Promotion Council of India, supported by Ministry of Commerce and Industry, GOI 2013 -the Company was awarded the India's most admired pharma company award for 2013 at the 6th Annual Pharmaceutical Leadership Summit in 2013 2014 -the Product `Clavam' was awarded as the ` Brand of the Year' at the AWACS Award, 2014 2016 -Alkem's Mandva Plant successfully obtains the Establishment Inspection Report from the US FDA -Alkem receives EIR from the US FDA for its Daman formulation facility

Registered Office

MIDC, Taloja

,,,      ,

Registrar Details

Link Intime India Pvt. Ltd.